Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion.

[1]  J. Leysen,et al.  Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions , 2003, Journal of neurochemistry.

[2]  J. Maloteaux,et al.  Opposite modulation of regulators of G protein signalling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum , 2002, Neuroscience Letters.

[3]  J. Kehrl,et al.  RGS2: a multifunctional regulator of G-protein signaling. , 2002, The international journal of biochemistry & cell biology.

[4]  Richard R. Neubig,et al.  Regulators of G-Protein signalling as new central nervous system drug targets , 2002, Nature Reviews Drug Discovery.

[5]  C. Cobbs,et al.  Second messengers regulate RGS2 expression which is targeted to the nucleus. , 2001, Biochimica et biophysica acta.

[6]  T. Nakagawa,et al.  Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned μ- or κ-opioid receptors , 2001 .

[7]  P. Insel,et al.  RGS-PX1, a GAP for Gαs and Sorting Nexin in Vesicular Trafficking , 2001, Science.

[8]  E. Nestler,et al.  Elevated levels of ΔFosB and RGS9 in striatum in Parkinson’s disease , 2001, Biological Psychiatry.

[9]  D. H. Park,et al.  Inducible RGS2 is a cross-talk regulator for parathyroid hormone signaling in rat osteoblast-like UMR106 cells. , 2001, Biochemical and biophysical research communications.

[10]  G. Milligan,et al.  Differential capacities of the RGS1, RGS16 and RGS–GAIP regulators of G protein signaling to enhance α2A‐adrenoreceptor agonist‐stimulated GTPase activity of Go1α , 2001 .

[11]  P. Pauwels,et al.  Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA , 2001, Neuroscience Letters.

[12]  P. Pauwels,et al.  Different regulation of RGS2 mRNA by haloperidol and clozapine , 2001, Neuroreport.

[13]  C. Dessauer,et al.  RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III , 2001, Nature.

[14]  T. Wilkie,et al.  G-protein signaling: Satisfying the basic necessities of life , 2000, Current Biology.

[15]  S. Burchett,et al.  Regulators of G Protein Signaling , 2000, Journal of neurochemistry.

[16]  R. Jope,et al.  Muscarinic Receptor Stimulation Increases Regulators of G-protein Signaling 2 mRNA Levels through a Protein Kinase C-dependent Mechanism* , 1999, The Journal of Biological Chemistry.

[17]  J. Maloteaux,et al.  Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment. , 1999, European journal of pharmacology.

[18]  J. Maloteaux,et al.  Dopamine receptor-modulated [ 35 S ]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats , 1999, Brain Research.

[19]  J. Hepler.  Emerging roles for RGS proteins in cell signalling. , 1999, Trends in pharmacological sciences.

[20]  Y. Itoyama,et al.  Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  T. Wieland,et al.  Regulators of G-protein signalling: a novel protein family involved in timely deactivation and desensitization of signalling via heterotrimeric G proteins , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  M. Farquhar,et al.  RGS proteins: more than just GAPs for heterotrimeric G proteins. , 1999 .

[23]  J. Granneman,et al.  RGS mRNA Expression in Rat Striatum , 1999, Journal of neurochemistry.

[24]  T. Herdegen,et al.  Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins , 1998, Brain Research Reviews.

[25]  R. Andrade,et al.  Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. , 1998, Molecular pharmacology.

[26]  Y. Jan,et al.  Evidence that the nucleotide exchange and hydrolysis cycle of G proteins causes acute desensitization of G-protein gated inward rectifier K+ channels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Barnes,et al.  Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity , 1998, The Journal of Neuroscience.

[28]  J. Granneman,et al.  Regulators of G Protein Signaling: Rapid Changes in mRNA Abundance in Response to Amphetamine , 1998, Journal of neurochemistry.

[29]  J. Granneman,et al.  Regulation of RGS mRNAs by cAMP in PC12 cells. , 1998, Biochemical and biophysical research communications.

[30]  E. Nestler,et al.  Regulators of G-Protein Signaling (RGS) Proteins: Region-Specific Expression of Nine Subtypes in Rat Brain , 1997, The Journal of Neuroscience.

[31]  M. Besson,et al.  Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons , 1997, Neuroreport.

[32]  J. Thorner,et al.  RGS Proteins and Signaling by Heterotrimeric G Proteins* , 1997, The Journal of Biological Chemistry.

[33]  D. G. Herrera,et al.  Activation of c-fos in the brain , 1996, Progress in Neurobiology.

[34]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[35]  H. Wang,et al.  Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity. , 1994, The Journal of pharmacology and experimental therapeutics.

[36]  R. Sullivan,et al.  Striatal G-proteins: Effects of unilateral 6-hydroxydopamine lesions , 1994, Neuroscience Letters.

[37]  T. Miyatake,et al.  Protein kinase C subspecies in hippocampus and striatum of reserpinized rat brain , 1994, Brain Research.

[38]  C. Verney,et al.  G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  E. Friedman,et al.  Repeated Reserpine Increases Striatal Dopamine Receptor and Guanine Nucleotide Binding Protein RNA , 1993, Journal of neurochemistry.

[40]  E. Richfield.  Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics , 1991, Brain Research.

[41]  M. Memo,et al.  Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding , 1989, Brain Research.

[42]  Y. Agid,et al.  [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. , 1988, European journal of pharmacology.

[43]  H. Schoemaker,et al.  Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  M. Dubocovich,et al.  Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes. , 1985, Biochemical pharmacology.

[45]  S. Snyder,et al.  [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. , 1984, Molecular pharmacology.

[46]  G. Breese,et al.  Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. , 1970, The Journal of pharmacology and experimental therapeutics.

[47]  P. Riederer,et al.  Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.

[48]  E M Ross,et al.  GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.

[49]  P. Riederer,et al.  Neurotransmitters and Disorders of the Basal Ganglia , 1999 .

[50]  D. Sibley,et al.  Regulation of Dopamine Receptor Function and Expression , 1997 .

[51]  K. Neve,et al.  Dopamine Receptors , 2008 .

[52]  P. Molinoff,et al.  Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .

[53]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .